News 12/11/24 – HIStalk
Top News
CVC Capital Partners will likely acquire German health IT company CompuGroup Medical in a take-private deal valued at $1.2 billion. The acquisition is expected to close in the first half of 2025.
CGM…
Top News
CVC Capital Partners will likely acquire German health IT company CompuGroup Medical in a take-private deal valued at $1.2 billion. The acquisition is expected to close in the first half of 2025.
CGM…
What You Should Know:
– Tandem Diabetes Care, an insulin pump manufacturer, has announced expanded compatibility for its t:slim X2™ insulin pump in Canada.
– In-warranty users can now integrate their pumps with both the Dexcom…
Continue ReadingIntroduction
Dexcom, a leader in continuous glucose monitoring (CGM) technology, has revolutionized diabetes management and ventured into broader health and wellness applications. With over 25 years of innovation, the company is forging partnerships and expanding…
Glucose-monitoring specialist Dexcom made several announcements this year, including receiving FDA clearance for its over-the-counter continuous glucose monitoring (CGM) solution Stelo, G7’s expanded capabilities to connect directly to the Apple Watch and, most recently,…
Continue ReadingGlucose-monitoring specialist Dexcom announced it has made a $75 million strategic investment in health-tracking ring maker Oura and established a strategic partnership to enable two-way data flow between Dexcom’s continuous glucose monitor (CGM) and…
Continue ReadingWhat You Should Know:
– DexCom, the global leader in continuous glucose monitoring (CGM), and ŌURA, the maker of the leading smart ring, have announced a strategic partnership to help millions of people improve their…
Continue ReadingWhat You Should Know:
– Abbott announced that its FreeStyle Libre 2 and 3 continuous glucose monitoring (CGM) systems have received FDA clearance for use during common imaging procedures, including X-rays, CT scans, and MRIs.
–…
Continue ReadingWhat You Should Know:
– Ascensia Diabetes Care has announced the U.S. launch of the Eversense® 365 continuous glucose monitoring (CGM) system, an advancement in diabetes management.
– Developed by Senseonics Holdings, Inc., Eversense 365 is…
Continue ReadingAn interdisciplinary team of researchers from various Chinese universities have developed a miniature-sized continuous glucose monitoring system that works as effectively as market-leading systems.WHAT IT’S ABOUT
The CGM sensor is made of an organic electrochemical…
What You Should Know:
– A research study by CCS, a leading chronic care management company, reveals that patients receiving continuous glucose monitoring (CGM) devices through medical benefits experience superior adherence and lower costs compared…
Continue Reading